Item 15. Exhibit and Financial Statement Schedules

**(a)**The following documents are filed as part of this report:

(1) Financial Statements:


			Page(s)
Report of Independent Registered Public Accounting Firm — PricewaterhouseCoopers LLP			60
Consolidated Statement of Income for the three years ended December 31, 2023			62
Consolidated Statement of Comprehensive Income for the three years ended December 31, 2023			63
Consolidated Balance Sheet at December 31, 2023 and 2022			64
Consolidated Statement of Cash Flows for the three years ended December 31, 2023			65
Consolidated Statement of Equity for the three years ended December 31, 2023			66
Notes to the Consolidated Financial Statements			67 to 101

(2) Financial Statement Schedules:

Included below is Schedule II - Valuation and Qualifying Accounts for each of the three years in the period ended December 31, 2023.

(3) Exhibits:

The Exhibit Index on the following pages lists the exhibits that are filed as part of this report.

Schedule II — Valuation and Qualifying Accounts


	Year ended December 31
Millions of Dollars	2023		2022		2021
Employee Termination Benefits
Balance at January 1	$	11	$	43	$	470
Additions (reductions) charged to expense	(2)		1		(30)
Payments	(3)		(33)		(397)
Balance at December 31	$	6	$	11	$	43
Expected Credit Losses
Beginning allowance balance for expected credit losses	$	1,008	$	745	$	671
Current period provision	(367)		263		74

Write-offs charged against the allowance, if any	—		—		—

Balance at December 31	$	641	$	1,008	$	745
Deferred Income Tax Valuation Allowance*
Balance at January 1	$	19,532	$	17,651	$	17,762
Additions to deferred income tax expense	2,348		3,533		3,691
Reduction of deferred income tax expense	(1,464)		(1,652)		(3,802)
Balance at December 31	$	20,416	$	19,532	$	17,651